views - 183
Shares of Trillium Therapeutics Inc. undefined nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced...
Click here to view full article source
Current Page - 1 out of 1
Current Page - 1 out of 1